| Date Filed | Type | Description |
| 09/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/21/2023 |
SC 13D/A
| New Enterprise Associates 15, L.P. reports a 50.7% stake in Bright Health Group, Inc. |
| 06/09/2023 |
SC 13D/A
| New Enterprise Associates 15, L.P. has filed a Schedule 13D for IonQ, Inc. |
| 01/24/2023 |
SC 13D/A
| New Enterprise Associates 15, L.P. reports a 10.8% stake in Arcellx, Inc. |
| 12/12/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/15/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/06/2022 |
SC 13D/A
| New Enterprise Associates 15, L.P. reports a 13.3% stake in IonQ, Inc. |
| 05/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/17/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/08/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/07/2022 |
SC 13G/A
| New Enterprise Associates 15, L.P. has filed a Schedule 13D for Inozyme Pharma, Inc. |
| 01/26/2022 |
SC 13D/A
| New Enterprise Associates 15, L.P. reports a 39% stake in Bright Health Group, Inc. |
| 12/29/2021 |
SC 13D/A
| New Enterprise Associates 15, L.P. reports a 34.7% stake in Bright Health Group, Inc. |
| 11/19/2021 |
SC 13G/A
| New Enterprise Associates 15, L.P. has filed a Schedule 13D for Annexon, Inc. |
| 10/21/2021 |
SC 13D
| New Enterprise Associates 15, L.P. reports a 15.2% stake in * IonQ, Inc. |
| 10/07/2021 |
SC 13D/A
| New Enterprise Associates 15, L.P. reports a 5.5% stake in Desktop Metal, Inc. |
| 08/26/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/16/2021 |
SC 13D
| New Enterprise Associates 15, L.P. reports a 17.2% stake in Berkshire Grey, Inc. |
| 06/22/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/03/2021 |
SC 13D/A
| New Enterprise Associates 15, L.P. reports a 11.7% stake in Eargo, Inc. |
| 04/23/2021 |
SC 13D
| New Enterprise Associates 15, L.P. reports a 19.8% stake in * Reneo Pharmaceuticals, Inc. |
| 04/13/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| New Enterprise Associates 15, L.P. has filed a Schedule 13D for * Annexon, Inc. |
| 12/28/2020 |
SC 13D
| New Enterprise Associates 15, L.P. reports a 12.5% stake in Desktop Metal, Inc. |
| 10/27/2020 |
SC 13D
| New Enterprise Associates 15, L.P. reports a 17.9% stake in Eargo, Inc. |
| 07/23/2020 |
SC 13D
| New Enterprise Associates 15, L.P. reports a 9.5% stake in Nkarta, Inc. |
| 06/12/2019 |
SC 13D/A
| New Enterprise Associates 15, L.P. has filed a Schedule 13D for Nightstar Therapeutics plc |
| 03/13/2019 |
SC 13D
| New Enterprise Associates 15, L.P. reports a 7.1% stake in Clementia Pharmaceuticals Inc. |
| 03/13/2019 |
SC 13D/A
| New Enterprise Associates 15, L.P. reports a 19.9% stake in Nightstar Therapeutics plc |
| 02/13/2019 |
SC 13G/A
| New Enterprise Associates 15, L.P. reports a 7.3% stake in Clementia Pharmaceuticals Inc. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/18/2018 |
SC 13D
| New Enterprise Associates 15, L.P. reports a 13.7% stake in Millendo Therapeutics, Inc. |
|